Heart Test Laboratories's gross profit for the
three
months ended in Jan. 2024 was $0.01 Mil. Heart Test Laboratories's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was $0.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Heart Test Laboratories's Gross Profit
For the Medical Devices subindustry, Heart Test Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Heart Test Laboratories's Gross Profit Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Gross Profit distribution charts can be found below:
* The bar in red indicates where Heart Test Laboratories's Gross Profit falls into.
Heart Test Laboratories Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Heart Test Laboratories's Gross Profit for the fiscal year that ended in Apr. 2023 is calculated as
Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Heart Test Laboratories (NAS:HSCS) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Heart Test Laboratories had a gross margin of 66.67% for the quarter that ended in Jan. 2024 => Durable competitive advantage
Heart Test Laboratories Gross Profit Related Terms
Thank you for viewing the detailed overview of Heart Test Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Heart Test Laboratories (Heart Test Laboratories) Business Description
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSCS has been successfully added to your 